(MF) Wendel - Ratings and Ratios
Equity, Business, Services, Healthcare, Technology
Dividends
| Dividend Yield | 7.66% |
| Yield on Cost 5y | 7.95% |
| Yield CAGR 5y | 9.33% |
| Payout Consistency | 85.8% |
| Payout Ratio | 57.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 19.5% |
| Value at Risk 5%th | 31.7% |
| Relative Tail Risk | -1.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.41 |
| Alpha | -10.90 |
| CAGR/Max DD | -0.02 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.470 |
| Beta | 0.246 |
| Beta Downside | 0.275 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.41% |
| Mean DD | 11.94% |
| Median DD | 10.39% |
Description: MF Wendel November 07, 2025
Wendel (ticker MF) is a Paris-based private equity firm with roots dating back to 1704, operating globally across Europe, North America, Africa, and Asia. It focuses on equity financing for middle-market and later-stage companies via leveraged buy-outs, acquisitions, and balance-sheet investments, targeting both listed and unlisted entities.
The firm’s sector coverage includes B2B services, education technology, energy transition, technology services, software, business services, healthcare, and industrial technology. Recent private-equity market data shows that B2B SaaS firms in Europe have been posting median revenue growth of ~25% YoY, while energy-transition assets have attracted a record €150 bn of capital in 2023, underscoring two of Wendel’s core growth drivers.
Investment size typically ranges from €300 million to €800 million, with a preference for majority, control, or large-minority stakes. Wendel routinely seeks board representation and participation in key committees, aligning governance with its long-term value-creation mandate.
Geographically, the firm concentrates on France and broader Western Europe, while also pursuing opportunities in the United States, Canada, and select African markets. Its diversified approach aims to mitigate regional cyclicality, a strategy supported by the fact that European private-equity exits have averaged a 2.4× multiple over the past five years.
For a deeper quantitative breakdown of Wendel’s portfolio exposure, you might explore ValueRay’s interactive dashboard.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (334.8m TTM) > 0 and > 6% of Revenue (6% = 717.4m TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 7.18pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 20.82% (prev 42.89%; Δ -22.08pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 2.96b > Net Income 334.8m (YES >=105%, WARN >=100%) |
| Net Debt (4.02b) to EBITDA (1.87b) ratio: 2.15 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (53.8m) change vs 12m ago 21.93% (target <= -2.0% for YES) |
| Gross Margin 59.03% (prev 12.52%; Δ 46.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 76.90% (prev 45.75%; Δ 31.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.04 (EBITDA TTM 1.87b / Interest Expense TTM 463.4m) >= 6 (WARN >= 3) |
Altman Z'' 2.82
| (A) 0.16 = (Total Current Assets 5.59b - Total Current Liabilities 3.10b) / Total Assets 15.70b |
| (B) 0.25 = Retained Earnings (Balance) 3.93b / Total Assets 15.70b |
| (C) 0.09 = EBIT TTM 1.41b / Avg Total Assets 15.55b |
| (D) 0.34 = Book Value of Equity 3.71b / Total Liabilities 11.02b |
| Total Rating: 2.82 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.56
| 1. Piotroski 7.0pt |
| 2. FCF Yield 33.05% |
| 3. FCF Margin 20.17% |
| 4. Debt/Equity 2.16 |
| 5. Debt/Ebitda 2.15 |
| 6. ROIC - WACC (= 7.08)% |
| 7. RoE 10.96% |
| 8. Rev. Trend -61.96% |
| 9. EPS Trend -36.76% |
What is the price of MF shares?
Over the past week, the price has changed by +4.79%, over one month by +6.65%, over three months by +2.66% and over the past year by -6.01%.
Is MF a buy, sell or hold?
What are the forecasts/targets for the MF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 113.8 | 40.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 87 | 7.5% |
MF Fundamental Data Overview December 12, 2025
Market Cap EUR = 3.27b (3.27b EUR * 1.0 EUR.EUR)
P/S = 0.383
P/B = 1.0695
P/EG = -0.33
Beta = 0.996
Revenue TTM = 11.96b EUR
EBIT TTM = 1.41b EUR
EBITDA TTM = 1.87b EUR
Long Term Debt = 5.61b EUR (from longTermDebt, last quarter)
Short Term Debt = 563.5m EUR (from shortTermDebt, last quarter)
Debt = 6.63b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.02b EUR (from netDebt column, last quarter)
Enterprise Value = 7.30b EUR (3.27b + Debt 6.63b - CCE 2.61b)
Interest Coverage Ratio = 3.04 (Ebit TTM 1.41b / Interest Expense TTM 463.4m)
FCF Yield = 33.05% (FCF TTM 2.41b / Enterprise Value 7.30b)
FCF Margin = 20.17% (FCF TTM 2.41b / Revenue TTM 11.96b)
Net Margin = 2.80% (Net Income TTM 334.8m / Revenue TTM 11.96b)
Gross Margin = 59.03% ((Revenue TTM 11.96b - Cost of Revenue TTM 4.90b) / Revenue TTM)
Gross Margin QoQ = 11.14% (prev 100.0%)
Tobins Q-Ratio = 0.46 (Enterprise Value 7.30b / Total Assets 15.70b)
Interest Expense / Debt = 2.18% (Interest Expense 144.8m / Debt 6.63b)
Taxrate = 33.37% (67.1m / 201.1m)
NOPAT = 938.4m (EBIT 1.41b * (1 - 33.37%))
Current Ratio = 1.80 (Total Current Assets 5.59b / Total Current Liabilities 3.10b)
Debt / Equity = 2.16 (Debt 6.63b / totalStockholderEquity, last quarter 3.07b)
Debt / EBITDA = 2.15 (Net Debt 4.02b / EBITDA 1.87b)
Debt / FCF = 1.67 (Net Debt 4.02b / FCF TTM 2.41b)
Total Stockholder Equity = 3.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.13% (Net Income 334.8m / Total Assets 15.70b)
RoE = 10.96% (Net Income TTM 334.8m / Total Stockholder Equity 3.05b)
RoCE = 16.26% (EBIT 1.41b / Capital Employed (Equity 3.05b + L.T.Debt 5.61b))
RoIC = 10.34% (NOPAT 938.4m / Invested Capital 9.07b)
WACC = 3.26% (E(3.27b)/V(9.90b) * Re(6.92%) + D(6.63b)/V(9.90b) * Rd(2.18%) * (1-Tc(0.33)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 10.67%
[DCF Debug] Terminal Value 78.65% ; FCFE base≈1.95b ; Y1≈2.00b ; Y5≈2.23b
Fair Price DCF = 926.0 (DCF Value 39.24b / Shares Outstanding 42.4m; 5y FCF grow 2.40% → 3.0% )
EPS Correlation: -36.76 | EPS CAGR: -36.24% | SUE: 0.0 | # QB: 0
Revenue Correlation: -61.96 | Revenue CAGR: -23.12% | SUE: 0.04 | # QB: 0
EPS next Year (2026-12-31): EPS=10.34 | Chg30d=-0.055 | Revisions Net=-1 | Growth EPS=+15.0% | Growth Revenue=+3.7%